SCHEMBL1635637

SCHEMBL1635637

CC(=O)OCC(=O)[C@H]1CC[C@H]2[C@@H]3C=C(C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.65
LMNA P02545 7/20 0.65
CYP3A4 P08684 6/20 0.65
SMN1; SMN2 Q16637 5/20 0.65
MEN1 O00255 4/20 0.65
KMT2A Q03164 4/20 0.65
MAPT P10636 3/20 0.65
PGR P06401 5/20 0.56
AR P10275 4/20 0.56
CYP2C9 P11712 4/20 0.56
NR3C1 P04150 3/20 0.56
ABCB11 O95342 3/20 0.56
MAPK1 P28482 3/20 0.56
HIF1A Q16665 3/20 0.56
NPSR1 Q6W5P4 2/20 0.56
POLB P06746 1/20 0.56
TDP1 Q9NUW8 1/20 0.55
CHRM1 P11229 3/20 0.55
CYP19A1 P11511 1/20 0.54
NR1I2 O75469 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11122934 0.90 ALDH1A1 (0.65) ALDH1A1LMNACYP3A4SMN1; SMN2MEN1
SCHEMBL13981881 0.86 CYP3A4 (0.66) ALDH1A1LMNACYP3A4SMN1; SMN2MEN1
SCHEMBL29882740 0.86 CYP3A4 (0.66) ALDH1A1LMNACYP3A4SMN1; SMN2MEN1
SCHEMBL18402585 0.86 CYP3A4 (0.66) ALDH1A1LMNACYP3A4SMN1; SMN2MEN1
SCHEMBL369752 0.86 CYP3A4 (0.66) ALDH1A1LMNACYP3A4SMN1; SMN2MEN1
SCHEMBL10380434 0.83 ALDH1A1 (0.74) ALDH1A1LMNACYP3A4SMN1; SMN2MEN1
SCHEMBL11204626 0.80 ALDH1A1 (0.72) ALDH1A1LMNACYP3A4SMN1; SMN2MEN1
SCHEMBL666683 0.80 CYP3A4 (0.58) ALDH1A1LMNACYP3A4SMN1; SMN2MEN1
Acetic Acid SCHEMBL29398143 0.79 ALDH1A1 (0.69) ALDH1A1LMNACYP3A4SMN1; SMN2MEN1
Desoxycorticosterone Acetate SCHEMBL23468085 0.78 ALDH1A1 (1.00) ALDH1A1LMNACYP3A4SMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7932382-B2 Amide substituted heterocylic compound; anticarcinogen; inducing apoptotic cell death, sensitizing cells to inducers of apoptosis THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2011-04-26 US disclosed
US-20090082445-A1 GOSSYPOL CO-CRYSTALS AND THE USE THEREOF THE REGENTS OF THE UNIVERSITY OF MICHIGAN 2009-03-26 US disclosed
WO-2008148473-A2 METHOD FOR THE PRODUCTION OF 17 ALPHA-ACETOXY-6-METHYLENEPREGN-4-ENE-3,20-DIONE, MEDROXYPROGESTERONE ACETATE, AND MEGESTROL ACETATE BAYER SCHERING PHARMA AG (DE) 2008-12-11 WO disclosed
US-20080269140-A1 Conformationally Constrained Smac Mimetics and the Uses Thereof THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2008-10-30 US disclosed
EP-0479867-A1 COMPOSITIONS USEFUL AS CONTRACEPTIVES IN MALES. COHEN MICHAEL (NL) 1992-04-15 EP disclosed
WO-1991000095-A1 COMPOSITIONS USEFUL AS CONTRACEPTIVES IN MALES COHEN MICHAEL (NL) 1991-01-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080269140-A1 Conformationally Constrained Smac Mimetics and the Uses Thereof BID, API5, BIRC3 ALDH1A1 4625/4885LMNA 144/4885CYP3A4 4804/4885
US-20090082445-A1 GOSSYPOL CO-CRYSTALS AND THE USE THEREOF BAX, BCL2, CASP8 ALDH1A1 4286/4885LMNA 1538/4885CYP3A4 3951/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.